Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 24, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Acute Decompensated Heart Failure
Interventions
DRUG

Acetazolamide

Patients will receive acetazolamide 500 mg once daily for 3 days as add on therapy to IV loop diuretics

DRUG

Dapagliflozin 10mg

patient will receive oral dapagliflozin 10 mg once daily for 3 days as add on therapy to IV loop diuretics

Trial Locations (1)

Unknown

RECRUITING

Critical Care Medicine Department - Cairo University Hospitals., Cairo

All Listed Sponsors
lead

Helwan University

OTHER